June 22-25 | San Diego

Novo Nordisk

Novo Nordisk's Partnering Priorities

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our primary strategic focus is in obesity, diabetes, and the related cardiometabolic diseases that impact these patients, including CVD, MASH and CKD, and rare blood disorders. In these areas, we are pioneering innovation, expanding access to our medicines, and working to prevent and ultimately cure disease.

We are looking for partners across all development stages to join us in this mission – with novel targets, new mechanisms of action or potentially disease-modifying compounds that can change the lives of people living with a serious chronic disease.

Tamara Darsow

Group Vice President, Global Business Development at Novo Nordisk

"Sharing the same dedication to getting innovation into the hands of millions of people living with obesity, diabetes and their related comorbidities, can unlock great potential. This is how we approach partnerships – committed, collaborative, leveraging each partner’s complementary capabilities."

Log in to BIO Partnering™ to send us a meeting request.

LOG IN

green line

Wimal Kapadia
Vice President, Search, Evaluation & Intelligence

Zaki Salanti
Scientific Advisor

Hong Chen
Director, Search & Evaluation (USA East)

Atul Jain
Director, Search & Evaluation (USA West)

Jenny Yang
Director, Search & Evaluation (Asia Pacific)

Eva Dahlen
Director, Search & Evaluation

Carlota Sancho
Director, Search & Evaluation

Hsin-Pei Shih
Director, Search & Evaluation

Sam Bennett
Associate Director, Search & Evaluation

Ryan Beltramini
Sr. Director, Business Development 

Dakota Campbell
Director, Business Development and M&A

Madeline Fitzgerald
Associate Director, Business Development 

Joe Festa
Sr. Manager, BD Transactions

Mark Kohn
Director, R&D External Innovation

Ja Young Kim-Muller
Associate Scientist Director, R&D External Innovation

Joshua Jacob
Digital Intelligence Director

Stephen Buckley
Sr. Scientific Director, Drug Product Research

Lars Linderoth
Sr. Director, Peptide Research

Bharat Mani
Scientific Director, Diabetes & Obesity Metabolic Research

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading